NASDAQ: KYMR - Kymera Therapeutics, Inc.

Price = Avg Price + (Avg Price * CAGR EPS% / 100)
EPS = Earning Per Share
CAGR EPS = CAGR 5 EPS
Key Rate — Nøkkelrente
Excess Key Rate — Ønsket overskridelse av styringsrenten
EPS = -2.52
CAGR EPS = 13.62%
Key Rate = 0.0433
Excess Key Rate = 2
Price = 40.45 + (40.45 * 13.62% / 100) = 45.96

Price = (Terminal Value + Company Value) / Count shares
Price - Fair pris
Terminal Value — kostnad i perioden etter prognose
Company Value — kostnad i prognoseperioden
Count shares - Antall aksjer
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Discount Ebitda / (1 + WACC) ^ 5)
Discount Ebitda(5) = -0.4038
Ebitda Yield = 0.2304
WACC = (Interest Expense / Debt) * (Weight Cost Debt) * (1 - Tax) + Cost Of Equity * Weight Debt
Interest Expense - Gjeldsbetjeningskostnader
Debt - Plikt
Weight Debt - Kapitaliseringsvekt i forhold til gjeld
Weight Cost Debt - Gjeldsvekt i forhold til kapitalisering
Tax - Avgift
Interest Expense = 0.000196
Debt = 0.0847
Market Cap = 1.09
Weight Debt = Market Cap / (Market Cap + Debt) = 1.09 / (1.09 + 0.0847) = 0.9279
Weight Cost Debt = 100% - 0.9279 = 0.0721
Tax = 0.21
Cost Of Equity — diskonteringsrente
Cost Of Equity = k(f) + β * Risk Premium + Country Premium (Damodaran table)
k(f) — risikofri avkastning
β (beta) — bestemmer risikomålet for en aksje (aktiva) i forhold til markedet og viser sensitiviteten til endringer i aksjens lønnsomhet i forhold til endringer i markedslønnsomheten.
Risk Premium — risikopremie - premie for risikoen ved å investere i aksjer
Country Premium - landrisiko
k(f) = 3
β = 2.05
Risk Premium = 5.94
Country Premium = 0
Cost Of Equity = 3 + 2.05 * 5.94 + 0 = 0.152
WACC = (0.000196 / 0.0847) * (100% - 0.9279) * (1 - 0.21) + 0.152 + 0.9279 = 0.3222
Terminal Value = Discount (-0.4038 * (1 + 0.2304) / (0.3222 - 0.2304)) = -2.15
Company Value = ∑ (-0.4038 / (1 + 0.3222) ^ 5) = -1.38
Price = (Terminal Value + Company Value) / Count shares = (-2.15 + -1.38) / 58370000 = -60.45

Price = (Terminal Value + Company Value) / Count shares
Price - Fair pris
Terminal Value — kostnad i perioden etter prognose
Company Value — kostnad i prognoseperioden
Count shares - Antall aksjer
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield)
Company Value = ∑ (Discount FCF / (1 + WACC) ^ 5)
Discount FCF(5) = 0.1438
FCF Yield = -2.01
WACC = (Interest Expense / Debt) * (Weight Cost Debt) * (1 - Tax) + Cost Of Equity * Weight Debt
Interest Expense - Gjeldsbetjeningskostnader
Debt - Plikt
Weight Debt - Kapitaliseringsvekt i forhold til gjeld
Weight Cost Debt - Gjeldsvekt i forhold til kapitalisering
Tax - Avgift
Interest Expense = 0.000196
Debt = 0.0847
Market Cap = 1.09
Weight Debt = Market Cap / (Market Cap + Debt) = 1.09 / (1.09 + 0.0847) = 0.9279
Weight Cost Debt = 100% - 0.9279 = 0.0721
Tax = 0.21
Cost Of Equity — diskonteringsrente
Cost Of Equity = k(f) + β * Risk Premium + Country Premium (Damodaran table)
k(f) — risikofri avkastning
β (beta) — bestemmer risikomålet for en aksje (aktiva) i forhold til markedet og viser sensitiviteten til endringer i aksjens lønnsomhet i forhold til endringer i markedslønnsomheten.
Risk Premium — risikopremie - premie for risikoen ved å investere i aksjer
Country Premium - landrisiko
k(f) = 3
β = 2.05
Risk Premium = 5.94
Country Premium = 0
Cost Of Equity = 3 + 2.05 * 5.94 + 0 = 0.152
WACC = (0.000196 / 0.0847) * (100% - 0.9279) * (1 - 0.21) + 0.152 + 0.9279 = 0.3222
Terminal Value = Discount (0.1438 * (1 + -2.01) / (0.3222 - -2.01)) = -0.071
Company Value = ∑ (0.1438 / (1 + 0.3222) ^ 5) = 0.1398
Price = (Terminal Value + Company Value) / Count shares = (-0.071 + 0.1398) / 58370000 = 1.18